BLISSGVS — Bliss GVS Pharma Share News
0.000.00%
- IN₹66.31bn
- IN₹64.93bn
- IN₹9.27bn
India's Bliss GVS Pharma up on completion of US FDA inspection
Brief: Bliss Gvs Pharma Got Establishment Inspection Report For Palghar Unit From US FDA
Brief: Bliss GVS Pharma Gets GMP Compliance Certificate From TGA For Palghar Unit
Brief: Bliss GVS Pharma March Quarter Consol Net Profit Falls
Brief: India's Bliss GVS Pharma Sept-Quarter Consol Net Profit Falls
Brief: Bliss Gvs Pharma Says LIC Buys Shares Constituting 0.145% Of Total Share Capital
Brief: Bliss GVS Pharma June Quarter Consol Profit Falls
Brief: Bliss GVS Pharma Reappoints Vipul B. Thakkar As CFO
Brief: Bliss GVS Pharma Completes Commissioning Of Phase-I For Multi-Product Facility At Palghar East
Brief: India's Bliss GVS Pharma Reports Lower Dec-Quarter Profit
Brief: India's Bliss GVS Pharma June-Qtr Consol Net Profit Falls
Brief: India's Bliss GVS Pharma Posts March-Qtr Consol Net Profit
Brief: Bliss GVS Pharma Approves Increase Of Foreign Portfolio Investors/Foreign Institutional Investors Limits To 74 Pct In Co
BSE Block Deal BLISS GVS-B 529,673 shares at 140.00 INR
Brief: India's Bliss GVS Pharma March Quarter Profit Rises
Brief: India's Bliss GVS Pharma March Qtr Profit Rises
Brief: Bliss GVS Pharma Says Unit Kremoint Pharma Acquires 60 Pct Stake In Eco—Rich Cosmetic India
Brief: Bliss GVS Pharma Gets $12 Mln For Sale Of Shares Of Kenya Unit
Brief: Bliss GVS Pharma Seeks Shareholders' Nod To Disinvest Step Down Unit